357 related articles for article (PubMed ID: 29299768)
1. Optimization, Biopharmaceutical Profile and Therapeutic Efficacy of Pioglitazone-loaded PLGA-PEG Nanospheres as a Novel Strategy for Ocular Inflammatory Disorders.
Silva-Abreu M; Calpena AC; Espina M; Silva AM; Gimeno A; Egea MA; García ML
Pharm Res; 2018 Jan; 35(1):11. PubMed ID: 29299768
[TBL] [Abstract][Full Text] [Related]
2. PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization.
Sánchez-López E; Egea MA; Cano A; Espina M; Calpena AC; Ettcheto M; Camins A; Souto EB; Silva AM; García ML
Colloids Surf B Biointerfaces; 2016 Sep; 145():241-250. PubMed ID: 27187188
[TBL] [Abstract][Full Text] [Related]
3. Flurbiprofen PLGA-PEG nanospheres: role of hydroxy-β-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy.
Vega E; Egea MA; Garduño-Ramírez ML; García ML; Sánchez E; Espina M; Calpena AC
Colloids Surf B Biointerfaces; 2013 Oct; 110():339-46. PubMed ID: 23743255
[TBL] [Abstract][Full Text] [Related]
4. Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery.
Vega E; Egea MA; Calpena AC; Espina M; García ML
Int J Nanomedicine; 2012; 7():1357-71. PubMed ID: 22457594
[TBL] [Abstract][Full Text] [Related]
5. New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9.
Sánchez-López E; Ettcheto M; Egea MA; Espina M; Calpena AC; Folch J; Camins A; García ML
Nanomedicine; 2017 Apr; 13(3):1171-1182. PubMed ID: 27986603
[TBL] [Abstract][Full Text] [Related]
6. Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration.
Abrego G; Alvarado H; Souto EB; Guevara B; Bellowa LH; Parra A; Calpena A; Garcia ML
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):261-70. PubMed ID: 25681744
[TBL] [Abstract][Full Text] [Related]
7. PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer's disease: in vitro and in vivo studies.
Silva-Abreu M; Calpena AC; Andrés-Benito P; Aso E; Romero IA; Roig-Carles D; Gromnicova R; Espina M; Ferrer I; García ML; Male D
Int J Nanomedicine; 2018; 13():5577-5590. PubMed ID: 30271148
[TBL] [Abstract][Full Text] [Related]
8. In vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration.
Cañadas C; Alvarado H; Calpena AC; Silva AM; Souto EB; García ML; Abrego G
Int J Pharm; 2016 Sep; 511(2):719-27. PubMed ID: 27480398
[TBL] [Abstract][Full Text] [Related]
9. Development of fluorometholone-loaded PLGA nanoparticles for treatment of inflammatory disorders of anterior and posterior segments of the eye.
Gonzalez-Pizarro R; Silva-Abreu M; Calpena AC; Egea MA; Espina M; García ML
Int J Pharm; 2018 Aug; 547(1-2):338-346. PubMed ID: 29800741
[TBL] [Abstract][Full Text] [Related]
10. PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions.
Vega E; Gamisans F; García ML; Chauvet A; Lacoulonche F; Egea MA
J Pharm Sci; 2008 Dec; 97(12):5306-17. PubMed ID: 18425815
[TBL] [Abstract][Full Text] [Related]
11. PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan.
Emami J; Maghzi P; Hasanzadeh F; Sadeghi H; Mirian M; Rostami M
Pharm Dev Technol; 2018 Jan; 23(1):41-54. PubMed ID: 28608760
[TBL] [Abstract][Full Text] [Related]
12. Tri/tetra-block co-polymeric nanocarriers as a potential ocular delivery system of lornoxicam: in-vitro characterization, and in-vivo estimation of corneal permeation.
Salama AH; Shamma RN
Int J Pharm; 2015 Aug; 492(1-2):28-39. PubMed ID: 26151106
[TBL] [Abstract][Full Text] [Related]
13. In vitro drug release behavior, mechanism and antimicrobial activity of rifampicin loaded low molecular weight PLGA-PEG-PLGA triblock copolymeric nanospheres.
Gajendiran M; Divakar S; Raaman N; Balasubramanian S
Curr Drug Deliv; 2013 Dec; 10(6):722-31. PubMed ID: 23701139
[TBL] [Abstract][Full Text] [Related]
14. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
15. Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy.
Zhang J; Li Y; Gao W; Repka MA; Wang Y; Chen M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1367-80. PubMed ID: 24935153
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of an HPLC-MS/MS Method for Pioglitazone from Nanocarriers Quantitation in Ex Vivo and In Vivo Ocular Tissues.
Miralles-Cardiel E; Silva-Abreu M; Calpena AC; Casals I
Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34063615
[TBL] [Abstract][Full Text] [Related]
18. The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres.
Lochmann A; Nitzsche H; von Einem S; Schwarz E; Mäder K
J Control Release; 2010 Oct; 147(1):92-100. PubMed ID: 20603166
[TBL] [Abstract][Full Text] [Related]
19. Formulation Development, Optimization, and In Vitro-In Vivo Characterization of Natamycin-Loaded PEGylated Nano-Lipid Carriers for Ocular Applications.
Patil A; Lakhani P; Taskar P; Wu KW; Sweeney C; Avula B; Wang YH; Khan IA; Majumdar S
J Pharm Sci; 2018 Aug; 107(8):2160-2171. PubMed ID: 29698725
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol-poly(ethylene) glycol nanocarriers for the transscleral delivery of sirolimus.
Elsaid N; Somavarapu S; Jackson TL
Exp Eye Res; 2014 Apr; 121():121-9. PubMed ID: 24530465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
